ENDRA Life Sciences Inc. (NDRA) — Institutional Holders, Q2 2026
10 institutional investment managers reported a NDRA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $819.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
NDRA in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSNew · +29,924 sh+$159.5K
- CITIZENS FINANCIAL GROUPNew · +28,400 sh+$151.4K
- Altium Capital ManagementAdded · +7,372 sh+$39.3K
- VANGUARD CAPITAL MANAGEMENTAdded · +4,523 sh+$24.1K
- Tower Research Capital (TRC)New · +58 sh+$309.00
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -6,168 sh-$32.9K
- UBS Group AGTrimmed · -84 sh-$448.00
- Caitong International Asset Management , LtdSold out · -4 sh-$21.00
NDRA 13F holders ranked 1–10 of 10
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Altium Capital Management#1 · 59,272 sh | 59,272 | $315.9K | 0.67% | +14.2% |
| 2 | CITADEL ADVISORS#2 · 29,924 sh | 29,924 | $159.5K | 0.00% | New |
| 3 | CITIZENS FINANCIAL GROUP#3 · 28,400 sh | 28,400 | $151.4K | — | New |
| 4 | GEODE CAPITAL MANAGEMENT#4 · 14,910 sh | 14,910 | $79.5K | 0.00% | -29.3% |
| 5 | VANGUARD FIDUCIARY#5 · 10,121 sh | 10,121 | $53.9K | 0.00% | 0.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT#6 · 7,339 sh | 7,339 | $39.1K | 0.00% | +160.6% |
| 7 | MORGAN STANLEY#7 · 3,546 sh | 3,546 | $18.9K | 0.00% | 0.0% |
| 8 | UBS Group AG#8 · 68 sh | 68 | $362.00 | 0.00% | -55.3% |
| 9 | Tower Research Capital (TRC)#9 · 58 sh | 58 | $309.00 | 0.00% | New |
| 10 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT#10 · 19 sh | 19 | $101.00 | 0.00% | 0.0% |
Funds that sold out of NDRA in Q2 2026 (1)
Held NDRA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Caitong International Asset Management , Ltd4 sh | 4 | $19.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.